JDOC Holdings
64 holdings in the fund's latest file; the data source updated it on Oct 5, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | ABBVIE INC COMMON STOCK | 8.43% | 2,858 | $751.1K |
| 2 | ELI LILLY AND COMPANY | 7.87% | 613 | $700.6K |
| 3 | MERCK & CO INC COMMON | 5.04% | 3,111 | $448.9K |
| 4 | JOHNSON & COMMON | 4.81% | 1,672 | $428.1K |
| 5 | THERMO FISHER SCIENTIFIC | 4.57% | 622 | $407.3K |
| 6 | NOVARTIS AG COMMON STOCK (NOVN.SW) | 4.49% | 2,840 | $399.7K |
| 7 | ASTRAZENECA PLC COMMON (AZN.L) | 3.95% | 2,233 | $351.6K |
| 8 | UNITEDHEALTH GROUP INC | 3.64% | 871 | $323.9K |
| 9 | ABBOTT LABORATORIES | 2.92% | 2,669 | $260.2K |
| 10 | DANAHER CORP COMMON | 2.69% | 1,120 | $239.7K |
| 11 | NOVO NORDISK A/S COMMON | 2.53% | 6,019 | $225.4K |
| 12 | IQVIA HOLDINGS INC | 2.25% | 777 | $200.6K |
| 13 | ARGENX SE COMMON STOCK | 2.25% | 218 | $200.3K |
| 14 | CVS HEALTH CORP COMMON | 2.21% | 2,274 | $196.6K |
| 15 | CENCORA INC COMMON STOCK | 2.10% | 604 | $186.7K |
| 16 | BRISTOL-MYERS SQUIBB CO | 2.02% | 2,935 | $179.5K |
| 17 | HUMANA INC COMMON STOCK | 1.92% | 441 | $171.3K |
| 18 | TAKEDA PHARMACEUTICAL CO (4502.T) | 1.86% | 4,600 | $165.3K |
| 19 | BIOGEN INC COMMON STOCK | 1.83% | 743 | $163.4K |
| 20 | ROCHE HOLDING AG COMMON (ROP.SW) | 1.77% | 377 | $157.5K |
| 21 | REGENERON | 1.76% | 213 | $156.6K |
| 22 | EDWARDS LIFESCIENCES | 1.75% | 1,827 | $155.6K |
| 23 | BAYER AG COMMON STOCK (BAYN.DE) | 1.54% | 2,707 | $137.3K |
| 24 | TEVA PHARMACEUTICAL (TEVA.TA) | 1.52% | 3,445 | $135.5K |
| 25 | VERTEX PHARMACEUTICALS | 1.47% | 260 | $131.2K |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 72.85%
- Switzerland: 7.52%
- United Kingdom: 5.05%
- Denmark: 3.55%
- Ireland: 0.60%
- Netherlands: 2.58%
- Japan: 3.26%
- Germany: 3.06%
- Israel: 1.52%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.